Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126073231 | 12607323 | 1 | I | 20160714 | 20160729 | 20160729 | EXP | JP-MALLINCKRODT-T201603290 | MALLINCKRODT | 35.00 | YR | M | Y | 55.00000 | KG | 20160729 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126073231 | 12607323 | 1 | PS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 10 MG (20 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 126073231 | 12607323 | 2 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 15 MG (30 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 126073231 | 12607323 | 3 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 20 MG (40 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 126073231 | 12607323 | 4 | C | OXINORM | OXYCODONE HYDROCHLORIDE | 1 | Oral | 10 MG, PRN | 0 | ||||||||||
| 126073231 | 12607323 | 5 | C | TAPENTA | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 200 MG | 0 | ||||||||||
| 126073231 | 12607323 | 6 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Oral | 75 MG | 0 | ||||||||||
| 126073231 | 12607323 | 7 | C | ZYPREXA | OLANZAPINE | 1 | Oral | 5 MG | 0 | ||||||||||
| 126073231 | 12607323 | 8 | C | MODIODAL | MODAFINIL | 1 | Oral | 100 MG | 0 | ||||||||||
| 126073231 | 12607323 | 9 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 50 MG | 0 | ||||||||||
| 126073231 | 12607323 | 10 | C | CERCINE | DIAZEPAM | 1 | Oral | 5 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126073231 | 12607323 | 1 | Cancer pain |
| 126073231 | 12607323 | 4 | Analgesic therapy |
| 126073231 | 12607323 | 5 | Analgesic therapy |
| 126073231 | 12607323 | 6 | Analgesic therapy |
| 126073231 | 12607323 | 7 | Product used for unknown indication |
| 126073231 | 12607323 | 8 | Product used for unknown indication |
| 126073231 | 12607323 | 9 | Product used for unknown indication |
| 126073231 | 12607323 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126073231 | 12607323 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126073231 | 12607323 | Lung neoplasm malignant |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126073231 | 12607323 | 1 | 20150113 | 20150202 | 0 | |
| 126073231 | 12607323 | 2 | 20150203 | 20150322 | 0 | |
| 126073231 | 12607323 | 3 | 20150323 | 20150404 | 0 | |
| 126073231 | 12607323 | 4 | 20150112 | 0 | ||
| 126073231 | 12607323 | 5 | 20141216 | 0 | ||
| 126073231 | 12607323 | 6 | 20141216 | 0 | ||
| 126073231 | 12607323 | 7 | 20141219 | 0 | ||
| 126073231 | 12607323 | 8 | 20150109 | 20150322 | 0 | |
| 126073231 | 12607323 | 9 | 20150111 | 0 | ||
| 126073231 | 12607323 | 10 | 20150111 | 20150322 | 0 |